SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-22-000040
Filing Date
2022-05-05
Accepted
2022-05-05 09:46:55
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20220331.htm   iXBRL 10-Q 1357489
2 EX-31.1 exhibit31-1x03x31x22.htm EX-31.1 9839
3 EX-31.2 exhibit31-2x03x31x22.htm EX-31.2 9848
4 EX-32.1 exhibit32-1x03x31x22.htm EX-32.1 4832
5 EX-32.2 exhibit32-2x03x31x22.htm EX-32.2 4825
  Complete submission text file 0001439222-22-000040.txt   5948265

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20220331.xsd EX-101.SCH 39587
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20220331_cal.xml EX-101.CAL 80924
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20220331_def.xml EX-101.DEF 146961
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20220331_lab.xml EX-101.LAB 512686
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20220331_pre.xml EX-101.PRE 332945
61 EXTRACTED XBRL INSTANCE DOCUMENT agio-20220331_htm.xml XML 913700
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 22894597
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences